1. Topical Lomefloxacin versus Topical Chloramphenicol in the Treatment of Acute Bacterial Conjunctivitis

   • A. Agius-Fernandez
   • A. Patterson
   • P. Sunder Raj

   Clinical Use 28 August 2012 Pages: 263 - 269

2. Comparison among Different Types, Dosages and Duration of Interferon Therapy in Chronic Hepatitis C

   • Giampaolo Bresci
   • G. Parisi
   • A. Capria

   Clinical Use 28 August 2012 Pages: 271 - 277

3. Pharmacokinetics and Efficacy of Low- Dose Ketoprofen in Postoperative Dental Pain

   • R.A. Seymour
   • P.J. Kelly
   • J.E. Hawkesford

   Clinical Use 28 August 2012 Pages: 279 - 284

4. New Statistical Proposals to Evaluate the Benefit/Risk Ratio of Long-Term Treatment of Depression

   • Philippe Lehert
   • M.F. Poirier-Littre
   • A. Galinowski

   Clinical Use 28 August 2012 Pages: 285 - 295

5. Clinical Efficacy of Sparfloxacin in Mycoplasmal Pneumonia

   • Takahiko Horiguchi
   • Soichi Tachikawa
   • Misuzu Handa

   Clinical Use 28 August 2012 Pages: 297 - 302

6. Treatment of Long- Term Psychiatric Disorders in the Managed Care Environment

   • Barbara Dickey
   • Sharon-Lise T. Normand
   • William Fisher

   Clinical Pharmacoeconomics 28 August 2012 Pages: 303 - 308

7. Pharmacokinetic Profile of Epidurally Injected Bupivacaine in Awake Patients

   • R.H.T. Taverne
   • T.I. Ionescu
   • A. Van Dijk

   Clinical Pharmacokinetic 28 August 2012 Pages: 309 - 317

8. Clinical Pharmacokinetics of Ferric Natural Protein in Iron-Deficient Females

   • A. López de Ocáriz
   • M. Simón
   • J. Honorato

   Clinical Pharmacokinetic 28 August 2012 Pages: 319 - 325

9. Carboplatin Dosage Formulae Can Generate Inaccurate Predictions of Carboplatin Exposure in Carboplatin/Paclitaxel Combination Regimens

   • Vinodh R. Nannan Panday
   • Laurence J.C. van Warmerdam
   • Jos H. Beijnen

   Clinical Pharmacokinetic 28 August 2012 Pages: 327 - 335

10. Recurrence Risk in Bipolar Manic- Depressive Disorders after Discontinuing Lithium Maintenance Treatment: An Overview

    • Ross J. Baldessarini
    • Leonardo Tondo

    Clinical Review 28 August 2012 Pages: 337 - 351

11. Effect of Adverse Drug Reactions on Length of Stay in Intensive Care Units

    • E. Vargas
    • J. Simón
    • A. Moreno

    Pharmacovigilance 28 August 2012 Pages: 353 - 360

12. Encapsulation of Commercially Available Losartan for Blinding Purposes Does Not Affect its Bioavailability

    • L. Nyman
    • Kristina Taure
    • P.-O. Lagerström

    Short Communication 28 August 2012 Pages: 361 - 365